Volatiles are frequently abused as inhalants. The methods used for identification are generally nonspecific if analyzed concurrently with ethanol or require an additional analytical procedure that employs mass spectrometry. A previously published technique utilizing a capillary flow technology splitter to simultaneously quantitate and confirm ethyl alcohol by flame ionization and mass spectrometric detection after headspace sampling and gas chromatographic separation was evaluated for the detection of inhalants. Methanol, isopropanol, acetone, acetaldehyde, toluene, methyl ethyl ketone, isoamyl alcohol, isobutyl alcohol, n-butyl alcohol, 1,1-difluoroethane, 1,1,1-trifluoroethane, 1,1,1,2-tetrafluoroethane (Norflurane, HFC134a), chloroethane, trichlorofluoromethane (Freon w -11), dichlorodifluoromethane (Freon w -12), dichlorofluoromethane (Freon w -21), chlorodifluoromethane (Freon w -22) and 1,2-dichlorotetrafluoroethane (Freon w -114) were validated for qualitative identification by this method. The validation for qualitative identification included evaluation of matrix effects, sensitivity, carryover, specificity, repeatability and ruggedness/robustness.
Introduction
Volatile organic compounds (VOCs) are commonly used as propellants in compressed air duster products and as solvents in other household and commercial products such as varnish, nail polish, glue, paint stripper and degreaser. These VOCs are hydrocarbons, ketones, alcohols and halogenated alkanes, with low to moderate molecular weights and low boiling points, allowing them to be inhaled in their gaseous state. As a result of being easy to obtain, they are frequently seen as a cheap and legal alternative to abusing other drugs by adolescents and young adults (1, 2) . Administration can be achieved through numerous methods, such as direct inhalation of compressed air duster products or breathing through solvent-soaked rags, and may be referred to by different terms such as huffing, sniffing, snorting, bagging, or spraying depending on the method of administration (3) . The abuse of inhalants produces euphoric and psychoactive effects occasionally resulting in severe toxicity or death, and is routinely encountered in forensic toxicology casework (4 -11) . Some inhalants, such as the fluorinated alkanes and Freons w are cardio-toxic and may cause fatal cardiac arrhythmias (7, 11) . Propellants used in air duster products are among the most frequently abused and can include 1,1-difluoroethane (DFE), 1,1,1-trifluoroethane (TFE) or 1,1,1,2-tetrafluoroethane (Norflurane, HFC-134a); however, there have been no reports of TFE or Norflurane in forensic toxicology literature. The abuse of nitrites results in the presence of the corresponding alcohol (isoamyl, isobutyl and n-butyl alcohols) in biological specimens and detection of the alcohol may be evidence of nitrite abuse (12) . Other commonly abused VOCs include toluene and methyl ethyl ketone (MEK), compounds found in paint strippers, industrial adhesives and solvents.
As a result of the increasing number of inhalant-related impairment cases and deaths over the past 5 years in the State of Florida (13) (14) (15) (16) (17) , the authors found it necessary to validate a method to qualitatively identify an extensive list of VOCs, including methanol, isopropanol, acetone, acetaldehyde, toluene, MEK, isoamyl alcohol, isobutyl alcohol, n-butyl alcohol, DFE, TFE, Norflurane, chloroethane, trichlorofluoromethane (Freon . Current methods used for the identification of VOCs are generally nonspecific if analyzed concurrently with ethyl alcohol, or require an additional analytical procedure employing mass spectrometry for identification. A previously published technique utilizing a capillary flow technology (CFT) splitter to simultaneously quantitate and confirm ethyl alcohol by flame ionization detector (FID) and mass spectrometric (MS) detection after headspace (HS) sampling and gas chromatographic (GC) separation was evaluated for the detection of VOCs (18) . The validation for qualitative identification included evaluation of matrix effects, sensitivity, carryover, specificity, repeatability and ruggedness/robustness.
Materials and methods

Chemicals, reagents and supplies
Human whole-blood and urine (catalog no., respectively, 44600-WB(F), 88121-CDF(F)) were from UTAK (Valencia, CA, USA) and verified to be negative for all target compounds. Methanol, acetone, acetaldehyde, toluene and isoamyl alcohol (catalog no., respectively, MX0484-1, AX0115-1, AX0025-4, TX0737-1, AX1440-3) were from EMD Chemicals (Gibbstown, NJ, USA); isopropanol and n-butyl alcohol (catalog nos., respectively, AH323-4, 024-1L) were from Burdick and Jackson (Muskegon, MI, USA); MEK (catalog no. M1260) was from Spectrum Chemical (Gardena, CA, USA); isobutyl alcohol (catalog no. 9044-01) was from JT Baker (Phillipsburg, NJ, USA); TFE (catalog no. 1100-3-07) was from Synquest Labs (Alachua, FL, USA Normal propanol internal standard was prepared at a concentration of 0.01% by volume (% v/v) in DI water. Stock standards of all compounds were prepared in DI water to eliminate the appearance of an additional solvent peak unless the compound did not have sufficient solubility in water. Toluene and MEK were prepared in methanol as the compounds may be seen in combination with case samples, toluene is not soluble in water and both compounds elute much later than methanol. Methanol did produce a large solvent peak, but did not interfere with the detection of toluene or MEK. The purchased Freon w mix was a solution in ethyl acetate prepared by the manufacturer. Ethyl acetate did produce a solvent peak, but eluted much later than all of the Freon compounds studied and therefore did not interfere with their detection. The specific solvent used for each compound is listed in Table I . Standards prepared from gas cylinders including DFE, TFE, Norflurane and chloroethane were sampled using a 1 mL gas-tight syringe and a gas fitting with a GC inlet septum on the gas cylinder. The gas was added to a sealed, weighed, 10 mL HS vial containing 10 mL of DI water. The vial was weighed again and the mass difference was used to calculate the concentration of the prepared stock solution. Standards prepared from liquid volatiles were made using the density of the compound to calculate the required volume and diluting the liquid into an appropriate solvent using gas-tight syringes.
Sample preparation
One milliliter of internal standard followed by 100 mL of positive and negative controls, blood and/or urine samples were transferred into 20 mL HS vials utilizing Reference w pipettes. Vials were sealed, crimped and then placed onto an autosampler for analysis.
Instrument conditions
The instrumentation and conditions used for analysis were described previously, but with an incorrect reference to the utilization of a Dean's Switch (18) . Actually, an Agilent (Palo Alto, CA, USA) CFT two-way splitter with makeup gas ( part no. G3180-61500) of similar design to the Dean's Switch was employed. The instrumentation consisted of an Agilent G1888 HS sampler with a 7890A series gas chromatograph (GC) equipped with a CFT two-way splitter with makeup gas, FID and 5975C series MS. The GC inlet liner was a 2 mm internal diameter deactivated direct inlet liner ( part no. 5181-8818) from Agilent. The analytical column used was a DB-ALC1 (Agilent) fused-silica capillary column with dimensions of 30 m Â 0.32 mm i.d. and a 1.8 mm film thickness. The terminal end of the analytical column was connected to the CFT two-way splitter with makeup gas. From the CFT two-way splitter, deactivated fused-silica columns (restrictors) were connected to each detector. The CFT two-way splitter with makeup gas was configured using a 1:1 split ratio to the FID and MS according to the manufacturer's instructions, with the exception of the flow rate, using fused-silica capillary restrictors with dimensions of 1.06 m Â 0.18 mm to the FID and 2.89 m Â 0.18 mm to the MS. The makeup gas of the restrictors was set at a constant flow rate of 2 mL/min, not a constant pressure of 3.8 psi as recommended by the manufacturer. Helium was used as the carrier gas and makeup gas. All gases were of ultrahigh purity. All samples were analyzed using the HS-GC-FID-MS described above with an HS oven temperature of 508C. The HS loop and transfer line temperatures were set at 70 and 908C, respectively. Vial equilibration was set at 20 min. The vial pressurization was set at 15 psi for 0.15 min. Injection, loop fill and loop equilibration times were set at 0.50, 0.15 and 0.05 min, respectively. Multi-HS extraction and vial shaking were set to off. The GC cycle time was set at 13.5 min. For the GC a constant helium flow rate of 3 mL/min was used. The injection port temperature was maintained at 908C with a 5:1 split injection of the HS and a septum purge flow of 3 mL/min. The initial GC oven temperature of 358C was held for 2 min and then ramped at 258C per minute to a final temperature of 908C, which was held for 4.3 min. The total GC run time was 8.5 min per sample. The FID temperature was maintained at 3008C with hydrogen, air and constant column plus helium makeup pressures of 40, 450 and 50 psi, respectively. The FID signal was zeroed at 0 min with a data collection rate of 10 Hz. The MS transfer line was maintained at 2808C. The MS source and quadrupole were maintained at 230 and 1508C, respectively. The MS electron multiplier voltage was set to a gain factor of 1 (tuned using Agilent Chemstation Gain Tune followed by Low Mass Auto Tune). The Scan range was set at 20 -200 with a threshold of 150 and a sample number of 4 which resulted in a scan rate of 2.02 scans/ s. The trace ion detection feature was turned on.
Results and discussion
Method validation
The method validation for qualitative identification included evaluation of matrix effects, sensitivity, carryover, specificity, repeatability and ruggedness/robustness. Standards prepared in three matrices (DI water, human urine and human whole blood) over a range of concentrations were analyzed using the procedure to evaluate matrix effects. Correlation between the instrument responses for whole-blood and urine standards were compared with aqueous standards by plotting the instrument response (response ratio compared with the n-propanol internal standard) and evaluating the coefficient of determination of the resulting curve. If the coefficient of determination was .0.98 and the calibration curves in DI water, urine and blood were visually similar and had similar slopes and y-intercepts, then it was determined that matrix effects were negligible for qualitative analysis and matrix-matched controls were not necessary. Whether or not matrix-matched controls were necessary for each compound is summarized in Table I . If matrix-matched controls were necessary, then subsequent validation experiments were performed in both blood and urine; otherwise, controls were prepared in DI water.
Sensitivity was evaluated by analyzing a series of decreasing concentrations in DI water, blood and urine. Criteria used for qualitative identification of each compound required a spectral library match of 80% or better, a Gaussian peak shape and a signal-to-noise ratio (S/N) for both FID and MS, as applicable, of greater than 3:1. One exception was the Freon w compounds that were evaluated based on the MS alone due to a lack of hydrocarbons and therefore lower response on the FID. Once the limit of detection (LOD) was identified, it was verified by analyzing at least one replicate in at least three subsequent experiments.
Carryover was evaluated by analyzing a matrix-matched blank containing internal standard immediately following the highest positive control evaluated for each compound in DI water, blood and urine. No carryover was observed for any compound studied.
Verified blank whole blood and urine were analyzed by this method to examine any potential matrix interferences. No matrix interferences were identified. Common volatiles were prepared and analyzed to verify the specificity of the method. The results are presented in Table II . Additionally, over 800 whole-blood case samples have been analyzed by this method with no biological interferences evident. The combination of HS sampling, gas chromatography (DB-ALC1 column) and dual detection by FID and MS provided for the specific identification of all volatiles studied. Although interferences from coeluting compounds may preclude the identification of one or both of the affected compounds when present in a mixture, misidentification would not be made upon examination of the mass spectral data. Examples include Freon 22 w and DFE; acetone and acetonitrile. All of the compounds that are reported to be commonly used in air duster products (TFE, Norflurane and DFE) were not fully resolved when present in a mixture, but each was able to be uniquely identified as seen in Figures 1 and 2 .
Replicates of prepared standards were analyzed to verify the precision of the method at a suitable control level. Standards, prepared in DI water or blood and urine, depending on the compound, were analyzed as three replicates in three different experiments for a total of nine replicates in DI water for those compounds with no demonstrated matrix effects and nine replicates in each blood and urine for those compounds with demonstrated matrix effects. Precision was evaluated by the response ratio of the compound relative to the n-propanol internal standard. The results are presented in Table I . The validation experiments were performed on multiple days and gave repeatable results.
Method application
The Palm Beach County Sheriff's Office (PBSO) Toxicology Unit analyzes antemortem whole blood and urine for all local, county and state law enforcement agencies located within Palm Beach County, Florida. All blood samples submitted to the laboratory are analyzed by the above-described method as part of blood alcohol analysis. Urine samples are analyzed only upon request or with an indication in the case history of inhalants. The Toxicology Unit typically analyzes 500 -600 specimens for criminal cases per year. In a two and a half year period, DFE was identified by this method in one urine and nine whole blood driving under the influence (DUI) case samples. Toluene was identified in one whole blood DUI case sample in this same time period. Blood samples in these cases were collected between 23 and 143 min after the related incident. The urine sample was collected 113 min after the related incident. Figure 2 . Scan mass spectra (20-200 scan range) for whole blood control containing 72 mg/mL TFE, 84 mg/mL Norflurane, 56 mg/mL DFE.
Identification of Volatiles by HS-GC-FID-MS 577
Selected case reports For eight of the cases identified above, police reports describing the incidents were available and are summarized below. All blood specimens were analyzed by this method for ethanol and other volatiles followed by a nine-panel enzyme-linked immunosorbent assay (ELISA) (amphetamines, barbiturates, benzodiazepines, carisoprodol, cocaine metabolite, methamphetamines, oxycodone/oxymorphone, opiates and cannabinoids) and liquid -liquid extraction (LLE) with scan GC-MS for other basic compounds. Positive results were confirmed and/or quantitated by LLE or solid-phase extraction followed by GC with FID or nitrogen phosphorus detection and/or GC-MS. The urine specimen was analyzed by this method for ethanol and other volatiles, a seven-panel ELISA (barbiturates, benzodiazepines, carisoprodol, cocaine metabolie, oxycodone/oxymorphone, opiates and cannabinoids) and LLE with scan GC-MS for other basic compounds. Positive results were confirmed by LLE or solid-phase extraction with GC-MS analysis.
Case 1
An officer responded to a report of a man unconscious in a vehicle for over 3 1 2 h. The officer discovered a 44-year-old male slumped over the steering wheel. While removing the keys from the ignition, the officer discovered one 10 oz can of Dust Off w on the front passenger seat and one between the driver's legs on the driver's seat. A white foamy substance was coming from the driver's mouth. The officer made several attempts to wake the driver with no success. Emergency medical services responded and was able to wake the man using a sternum rub. The driver was disoriented, pupils were dilated and his speech was thick and slurred. The driver was making incoherent statements and when asked if he was ok, he stated 'No, I just did three cans'. The driver was unable to maintain balance and had to be assisted from his car. The driver was transported to the hospital for medical attention. The officer reported that the driver's eyes were back to normal within a half hour, but his speech continued to be slow and slurred.
Blood was collected from the driver 45 min after initial contact by the officer and found to contain DFE and lamotrigine.
Case 2
A witness observed one 31-year-old male driver inhaling from a bottle containing unknown substances in a parked vehicle in a parking lot of a shopping plazza and notified a police officer. The bottle was identified later as containing contact cement. The officer observed that the cement was inside the driver's nose, mouth, on his lips, his chin and neck. The driver's nasal discharge was all over his shirt and pants. He was extremely lethargic and unsteady. The blood was collected 76 min after the initial contact and found to contain toluene. MEK was also identified, but not confirmed, as the method was not validated for MEK at the time of reporting.
Case 3
A 25-year-old male drove over the median, across three lanes of oncoming traffic, onto the sidewalk and struck a concrete wall. He appeared to be confused and disoriented. His eyes were glassy and the pupils were dilated. At the crash scene, an extremely cold can containing unknown substance was located in the driver's seat. Toxicological analysis of the blood collected 1 h after the crash revealed that the blood contained DFE, delta-9 tetrahydrocannabinol (THC) at ,2.5 ng/mL, 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (delta-9-carboxy THC) at 26 ng/mL, benzoylecgonine at .1,000 ng/mL, alprazolam at 29 ng/mL, clonazepam at ,20 ng/mL and diphenhydramine at 35 ng/mL.
Case 4
A 32-year-old male ran a red light causing a three-vehicle crash with serious injuries. After the crash, the male driver tried to flee the scene on foot but was apprehended by witnesses. His speech was slow. The drug recognition expert (DRE) on the scene observed distinct and sustained nystagmus in both eyes. A full DRE examination was not performed. Toxicological analysis revealed that the blood collected 70 min after the crash contained DFE, alprazolam at 58 ng/mL, benzoylecgonine at 76 ng/mL, oxycodone at 38 ng/mL and ethanol at 0.07 g/dL.
Case 5
A 40-year-old female driver was involved in a single-vehicle crash in which the vehicle struck a tree. Witnesses to the crash stated that the vehicle ran up on the curb and accelerated into the tree. During the accident investigation, a police officer found a cold frosted can of aerosol cleaner on the driver's side floorboard. A blood sample was collected 60 min after the accident and was shown to contain DFE and diphenhydramine at 248 ng/mL.
Case 6
A 20-year-old female driver was involved in a single-vehicle crash in which the vehicle struck multiple bushes, trees and a sign. The driver stated that she lost control of her vehicle and 'spun out'. She indicated that she was traveling 45-50 mph in a 35 mph zone and that she had only a small amount to drink, but had just consumed some 'duster'. The driver went on to say that she had just picked up a can of 'duster' from Walmart and she had inhaled or 'huffed' the contents to get high. The officer recovered a can labeled Ultra Duster TM on the front passenger seat. A blood sample was collected 25 min after the incident and was shown to contain DFE, delta-9-THC at ,2.5 ng/mL and delta-9-carboxy THC at 17 ng/mL.
Case 7
A 20-year-old female driver was involved in a three-vehicle crash. A witness indicated that he was directly behind the driver at a stop light. When the light turned green, the witness indicated that he honked his horn to get the driver to move. The witness said that the driver accelerated slowly at first then accelerated rapidly entering the median, driving over bushes. The witness stated that the driver then crossed the other lanes of travel, drove through 2 yards and struck two cars. The witness said that the driver made no attempt to brake or avoid the collision.
The driver informed the officer that she lost control going over a speed bump. Since the driver seemed lethargic and confused, the officer asked where she was coming from and she stated Walmart. The driver stated that she had bought computer keyboard duster. In a sworn taped interview, the driver admitted to 'huffing' the duster while she was stopped at the red light. An officer located the open can of duster on the passenger floorboard. A blood sample was collected 50 min after the accident and was shown to contain DFE, delta-9-THC at ,2.5 ng/mL and delta-9-carboxy THC at 4 ng/mL.
Case 8
An officer responded to a report of a disabled vehicle in the roadway. The officer approached the vehicle, which was sitting in a turning lane and observed a 32-year-old female sitting in the driver's seat unconscious. The officer observed a large white can of dust remover in her right hand and smelled a strong odor of aerosol fumes coming from the vehicle. The front tire was flat and the rim was bent. The officer made contact with the driver who became aware but disoriented. Her face was flushed and wet from perspiration. Upon waking, the driver slowly moved and tried to hide the can of duster under her seat. As she did, the officer heard metal sounds from under the seat. The driver continued to be disoriented and weak on her feet, so the officer assisted her as she stood. The driver stated that she takes 2 mg Xanax w two times a day. She admitted to huffing dust remover. The officer located 12 empty dust remover cans inside the vehicle. The driver was transported to the breath alcohol testing center at PBSO and given a breath test. Results indicated that an interferant was present. A urine sample was collected 113 min after initial contact with the officer, and found to contain, by toxicological analysis, DFE, diphenhydramine, alprazolam and alpha-hydroxyalprazolam.
Conclusion
The abuse of VOCs can lead to significant impairment consistent with other central nervous system depressants, and a sensitive and specific analysis is necessary for their detection. Most toxicology laboratories use HS-GC-FID with either single or dual analytical columns to test for ethanol and other VOCs. While the FID has sufficient sensitivity and the use of dual columns with different selectivity enhances the specificity of the method, no structural data are obtained and therefore unequivocal confirmation is not possible. Assurance that an HS-GC-FID method is specific for ethanol or other VOCs is based an exhaustive evaluation of potential interferences by the volatile, low-molecular-weight compounds that may be present in human blood samples that have the potential to interfere with the target compound. While this may be a very limited number to evaluate for ethanol, the list may be much larger for other VOCs and an exhaustive validation may not be practicable or possible. The validated FID-MS method presented provides a robust procedure for the quantitation of ethyl alcohol in blood by FID with simultaneous, undisputable confirmation by MS (18) and can also be utilized as an identification method for inhalants such as DFE and toluene in blood and urine samples.
